Following outrage over bumping up the price of a drug 5,000 percent, CEO says he'll lower the cost


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
After swift backlash from consumers and advocacy groups, the CEO of a pharmaceutical startup that increased the price of a life-saving drug from $13.50 a pill to $750 announced Tuesday the company would lower the cost.
Martin Shkreli of Turing Pharmaceuticals did not divulge the new price, and said it would probably be set sometime over the next few weeks and would allow the company to break even or make a smaller profit. He told NBC News the decision was made due to the outrage the company faced over increasing the cost of Daraprim 5,000 percent overnight. "Yes, it is absolutely a reaction — there were mistakes made with respect to helping people understand why we took this action," he said. "I think that it makes sense to lower the price in response to the anger that was felt by people."
Daraprim is used to treat toxoplasmosis, which infects people with compromised immune systems due to AIDS, pregnancy, and chemotherapy, the CDC said. Turing acquired Daraprim in August, and on Monday said the price was increased because the company needed to "turn a profit on the drug," since research is costly and they want to come up with a newer version of Daraprim.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Lost and found
Cartoons
By The Week Staff Published
-
10 things you need to know today: September 24, 2023
Daily Briefing Nagorno-Karabakh's Armenian population to leave region amid fears of persecution, Atlantic coast remains under flood warnings from Ophelia, and more
By Justin Klawans Published
-
6 new horror novels to read this fall
The Explainer These upcoming releases will have you on the edge of your seat — or hiding under the covers
By David Faris Published
-
More than 2,000 dead following massive earthquake in Morocco
Speed Read
By Justin Klawans Published
-
Mexico's next president will almost certainly be its 1st female president
Speed Read
By Peter Weber Published
-
North Korea's Kim to visit Putin in eastern Russia to discuss arms sales for Ukraine war, U.S. says
Speed Read
By Peter Weber Published
-
Gabon's military leader sworn in following coup in latest African uprising
Speed Read
By Justin Klawans Published
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances
Speed Read
By Peter Weber Published
-
Western mountain climbers allegedly left Pakistani porter to die on K2
Speed Read
By Justin Klawans Published
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor
Speed Read
By Peter Weber Published
-
Los Angeles city workers stage 1-day walkout over labor conditions
Speed Read
By Justin Klawans Published